Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

Image-guided percutaneous needle biopsies after NST identify breast cancer patients who achieve pCR

In a pilot study conducted at The University of Texas MD Anderson Cancer Center, image-guided biopsies identified select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy and/or targeted therapy, neoadjuvant systemic therapy (NST).

9 Dec 2016

Jets of plasma used in arc welding may help kill cancer cells and heal wounds

JETS of plasma traditionally used in arc welding could soon be used to kill cancer cells and heal wounds.

9 Dec 2016

Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment

The first ever Proton Partners International site, specialising in proton beam therapy, has acquired a Blue Phantom2 data acquisition system from IBA to commission its IBA Proteus ONE compact proton therapy machine and Elekta Versa HD linear accelerator.

9 Dec 2016

Implant reconstruction after radiation leads to complications, less satisfaction in breast cancer patients

Many breast cancer patients who have a mastectomy will consider breast reconstruction. But for a portion of these women, radiation therapy is also recommended - and that can alter the tissue around the breast, impacting reconstruction efforts.

9 Dec 2016

Scientists discover new biomarker to help determine aggressiveness of brain cancer

Researchers at UT Southwestern Medical Center have found a new biomarker for glioma, a common type of brain cancer, that can help doctors determine how aggressive a cancer is and that could eventually help determine the best course of treatment.

6 Dec 2016

Metabolic pathway that shows potential to slow aging may drive brain cancer

While a particular metabolic pathway shows potential to slow down the aging process, new research indicates a downside: That same pathway may drive brain cancer.

6 Dec 2016

Clonal hematopoiesis may help predict cancer patients at risk for fatal form of leukemia

Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as therapy-related myeloid neoplasms (t-MNs).

4 Dec 2016

Researchers show how microRNAs play key role in tumor progression and response to radiation

OHSU researcher Sudarshan Anand, Ph.D., has a contemporary analogy to describe microRNA: "I sometimes compare MicroRNA to tweets -- they're short, transient and constantly changing."

2 Dec 2016

Researchers identify simple, inexpensive tool for assessing prognosis of pediatric brain tumors

A multi-institutional group of researchers, led by investigators at Children's Hospital Los Angeles and the University of Michigan, have identified a simple and inexpensive tool for assessing the prognosis of pediatric brain tumors called ependymomas.

23 Nov 2016

New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

A new class of therapies may be on the horizon for thyroid eye disease (TED) and other destructive scarring conditions.

11 Nov 2016

Second opinions may not reduce overtreatment in prostate cancer, study suggests

A new analysis indicates that many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes in treatment choice or improvements in perceived quality of prostate cancer care.

8 Nov 2016

FDA approves new combo treatment for patients with advanced sarcomas

There are approximately 15,000 sarcoma cases annually in the United States, comprising more than 60 types of soft tissue sarcomas and 20 types of bony sarcomas.

7 Nov 2016

World Cancer Congress: DITTA urges development of integrated care approaches in medical technology

In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.

4 Nov 2016

IDoR 2016 spotlights role of radiology in diagnosis and management of breast diseases

On Tuesday, Nov. 8, more than 140 medical societies worldwide will mark the International Day of Radiology, celebrating the thousands of lives saved by the many contributions of breast imagers and radiation oncologists.

2 Nov 2016

High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

High out-of-pocket costs, rather than race or ethnicity, are responsible for disparities associated with adherence to adjuvant endocrine therapy, according to a new study from researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.

1 Nov 2016

Radiation Therapy News and Research

Further Reading

Image-guided percutaneous needle biopsies after NST identify breast cancer patients who achieve pCR

Jets of plasma used in arc welding may help kill cancer cells and heal wounds

Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment

Implant reconstruction after radiation leads to complications, less satisfaction in breast cancer patients

Scientists discover new biomarker to help determine aggressiveness of brain cancer

Metabolic pathway that shows potential to slow aging may drive brain cancer

Clonal hematopoiesis may help predict cancer patients at risk for fatal form of leukemia

Researchers show how microRNAs play key role in tumor progression and response to radiation

Researchers identify simple, inexpensive tool for assessing prognosis of pediatric brain tumors

New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

Second opinions may not reduce overtreatment in prostate cancer, study suggests

FDA approves new combo treatment for patients with advanced sarcomas

World Cancer Congress: DITTA urges development of integrated care approaches in medical technology

IDoR 2016 spotlights role of radiology in diagnosis and management of breast diseases

High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

Penn study reveals new sights into how some intestinal cells can withstand chemotherapy and radiation

Robot-assisted surgery at NYU Lutheran offers hope to women with endometrial cancer

Targeting TASINs can be viable approach for preventing colon cancer, research reveals

Yale researchers identify chemical inhibitor that limits growth of lung tumor cells

Innovative combined therapy could effectively fight tumors

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News